Case report of radiotherapy combined with anlotinib and immunotherapy for a patient with esophageal cancer and esophageal fistula
CONCLUSION: After radiation therapy, the patient continued to be treated with anlotinib and immunotherapy with camrelizumab, and the patient's lesion improved.PMID:38142544 | DOI:10.1016/j.apradiso.2023.111162
Source: Applied Radiation and Isotopes - Category: Radiology Authors: Lumei He Qian Han Mingming Zhao Haodong Ma Peng Cheng Hongjie Yang Yang Zhao Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | CT Scan | Esophagus Cancer | Gastroenterology | Immunotherapy | Pathology | PET Scan | Radiation Therapy | Radiology | Skin Cancer | Squamous Cell Carcinoma | Tracheal Cancer | Tracheo-Esophageal Fistula